|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase Ⅲ trial显示文摘 | Reni M Cordio S Milandri C | 2005 | Lancet Oncol2005，6，： | 1 |
| 2 | Gemcitabine versus cisplatin,epirubicin, 5 - fluorouracil, gemcitabine in advanced pancreaticcancer: a phase III trial显示文摘 | Reni M Cordio S Milandri C | 2005 | Lancet Oncol2005，6，： | 1 |
| 3 | Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer:results of a randomized phase II study显示文摘 | Rosati G Cordio S Bordonaro R | 2010 | Ann Oncol2010，21，4： | 1 |
| 4 | Gemcitabine versus cisplatin,epirubicin,fluorouracil,and gemcitabine in advanced pancreatic cancer:a randomized controlled multicentre phase Ⅲ trial显示文摘 | Reni M Cordio S Milandri C | 2005 | Lancet Oncol2005，6，6： | 1 |
| 5 | Gemcitabine versus cisplatin,epirubicin,fluorouracil,and gemcitabine in advanced pancreatic cancer:a randomized controlled multicentre phase Ⅲ trial显示文摘 | Reni M Cordio S Milandri C | | 0，，6： | 1 |
| 6 | Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: A randomized controlled muhicentre phase III trial显示文摘 | RENI M CORDIO S MILANDRI C | 2005 | Lancet Oncol2005，6，： | 1 |
| 7 | Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomized phase II study显示文摘 | Rosati G Cordio S Bordonaro R | 2010 | Ann Oncol2010，21，4： | 1 |
| 8 | Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled muhicentre phase Ⅲ trial 显示文摘 | Reni M Cordio S Milandri C | 2005 | Lancet Oncol2005，6，6： | 1 |
| 9 | Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase Ⅲ trial显示文摘 | Reni M Cordio S Milandri C | 2005 | Lancet Oncol2005，6，6： | 1 |
| 10 | Non-Surgical Treatment with Primary Chemotherapy, with or without Radiation Therapy, of Stage I-II High-Grade Gastric Lymphoma显示文摘 | AndréS J. M. Ferrer Stefano Cordio Maurilio Ponzoni Eugenio Villa | 1999 | Leukemia & Lymphoma (-)1999，，5： | 1 |
| 11 | Preoperative fluo- rouracil (FU) based chemoradiation with and without weekly ox- aliplat in inlocally advanced rectal cancer: Pathologic response analysis of the Studio Terapia A diuvante Retto (STAR)-01 ran- domized phase Ⅲ trial 显示文摘 | ASCHELE C PINTO C CORDIO S | 2009 | J Clin Oncol2009，27，18： | 1 |
| 12 | Single-agent irinotecan as second-lined weelcly chemotherapy in elderly patients with advaced colorectal cancer显示文摘 | Cordio S | 2006 | Tumori2006，92，4： | 1 |
| 13 | Gemcitabine versus cisplatin,epirubicin,fluorouracil,and gemcitabine in advaneed pancreatic cancer:a randomized controlled multicentre phase Ⅲ trial显示文摘 | Reni M Cordio S Milandri C | 2005 | Lancet Oncol2005，6，6： | 1 |
| 14 | Therapeutic management of stage Ⅰ -Ⅱ high-grade primary gastric lymphomas显示文摘 | Ferreri AJ Cordio S Paro S | 1999 | Oncology1999，56，： | 1 |
| 15 | Discontinuation ofbevacizumab and FOLFIRl administered up to a maximum of 12 cycles as first-line therapy for metastatic colorectal cancer: a retrospective Italian study显示文摘 | Rosati G Cordio S Aprile G | 2012 | Invest New Drugs2012，30，5： | 1 |
| 16 | Preoperative fluorouracil (FU)-based chemoradiation with and without weekly oxaliplatin in locally advanced rectal cancer:Pathologic response analysis of the Studio Terapia Adiuvante Retto (STAR)-01 randomized phase Ⅲ trial显示文摘 | Aschele C Pinto C Cordio S | 2009 | J Clin Oncol2009，27，18： | 1 |
| 17 | Final results of a phase Ⅲ trial of gemcitabine (G) versus PEFG regimen in stage ⅣAor metastatic pancreatic adenocarcinoma(PA) 显示文摘 | Reni M Cordio S Passardi A | 2004 | J Clin Oncol2004，22，14： | 1 |
| 18 | Totally implantablevenous access devices implanted surgically : a retrospectivestudy on early and late complications显示文摘 | Di Carlo I Cordio S La Greca G | 2001 | Arch Surg2001，136，： | 1 |
| 19 | Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: A randomised controlled muhicentre phase III trial显示文摘 | Reni M Cordio S Milandri C | 2005 | Lancet Oncol2005，6，6： | 1 |
| 20 | Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomized controlled multicentre phase Ⅲ trial 显示文摘 | Reni M Cordio S Milandri | 2005 | Lancet Oncol2005，6，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员